ICUI vs. ATRI, MMSI, HAE, TNDM, IART, NARI, PRCT, ATEC, LMAT, and AXNX
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Atrion (ATRI), Merit Medical Systems (MMSI), Haemonetics (HAE), Tandem Diabetes Care (TNDM), Integra LifeSciences (IART), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Alphatec (ATEC), LeMaitre Vascular (LMAT), and Axonics (AXNX). These companies are all part of the "surgical & medical instruments" industry.
Atrion (NASDAQ:ATRI) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, community ranking, profitability, analyst recommendations, valuation and dividends.
ICU Medical received 254 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.48% of users gave ICU Medical an outperform vote while only 55.60% of users gave Atrion an outperform vote.
Atrion has higher earnings, but lower revenue than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
Atrion has a net margin of 11.46% compared to Atrion's net margin of -1.31%. ICU Medical's return on equity of 8.07% beat Atrion's return on equity.
66.2% of Atrion shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 22.8% of Atrion shares are owned by insiders. Comparatively, 6.7% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Atrion has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.
ICU Medical has a consensus target price of $123.00, suggesting a potential upside of 23.79%. Given Atrion's higher probable upside, analysts plainly believe ICU Medical is more favorable than Atrion.
In the previous week, Atrion had 1 more articles in the media than ICU Medical. MarketBeat recorded 6 mentions for Atrion and 5 mentions for ICU Medical. Atrion's average media sentiment score of 0.51 beat ICU Medical's score of 0.44 indicating that ICU Medical is being referred to more favorably in the news media.
Summary
Atrion beats ICU Medical on 9 of the 17 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ICU Medical Competitors List
Related Companies and Tools
